Cas:607-67-0 2-Methyl-4-quinolinol manufacturer & supplier

Chemical Name:2-Methyl-4-quinolinol

CAS.NO:607-67-0

Synonyms:2-methyl-1H-quinolin-4-one;2-Methylquinolin-4-one;4-Hydroxy-2-methylquinoline;MFCD00006758;4-Quinolinol, 2-methyl-;EINECS 210-140-6;2-Methyl-4-quinolinol;2-methylquinolin-4(1H)-one;2-methylquinolin-4-ol

Molecular Formula:C₁₀H₉NO

Molecular Weight:159.185

HS Code:

Physical and Chemical Properties:

Melting point:234-236 °C(lit.)

Boiling point:270.8±40.0 °C at 760 mmHg

Density:1.1±0.1 g/cm3

Index of Refraction:1.574

PSA:33.12000

Exact Mass:159.068420

LogP:3.09

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like 2-methyl-1H-quinolin-4-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-methylquinolin-4-ol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Methyl-4-quinolinol Use and application,2-methyl-1H-quinolin-4-one technical grade,usp/ep/jp grade.

Related News: Mankind Pharmaceuticals on Monday said it has inked a licensing pact with Glenmark Pharmaceuticals to co-market diabetes drug Remogliflozin Etabonate in the country. 2-Methyl-4-quinolinol manufacturer Our quality control staff then conducts analyses in the testing laboratory to examine whether the API manufactured is ultrapure. 2-Methyl-4-quinolinol supplier Our previous work with Retrogenix validated their technology as a uniquely powerful approach for antibody target deconvolution, and we look forward to working with Retrogenix to enhance our growing pipeline of antibody candidates.�� 2-Methyl-4-quinolinol vendor Under the terms of the agreement, ICIG will purchase substantially all of the pharmaceutical intermediates business, excluding the drug delivery technologies portion of the business. 2-Methyl-4-quinolinol factory Our previous work with Retrogenix validated their technology as a uniquely powerful approach for antibody target deconvolution, and we look forward to working with Retrogenix to enhance our growing pipeline of antibody candidates.��